Dendrorchis pampae sp. n. (Digenea: Gorgoderidae) from Cynopoecilus melanotaenia (Cyprinodontiformes: Cynolebiidae) a killifish from southern Brazil, with an emended diagnosis of Dendrorchis.

A new species of Dendrorchis is described and compared with others in the genus. The parasites were found in the swim bladder of the annual killifish Cynopoecilus melanotaenia. Hosts were collected from a seasonal wetland in southern Brazil. The main characteristics of D. pampae are: genital pore in the intestinal bifurcation region elongate and lobed vitellaria uterine loops limited to the acetabular region and to the rear end of the body; and wide intestinal caeca. An emended diagnosis of the genus Dendrorchis includes the characteristics of the new species. This is the first record of an adult digenean in an annual killifish from South America.

Helminth fauna of Megaleporinus obtusidens (Characiformes: Anostomidae) from Lake Guaíba: analysis of the parasite community.

ABTRACT: Structure of the helminth community of Megaleporinus obtusidens collected in Lake Guaíba was evaluated, and the results indicated that the diversity of helminth species was probably determined by fish behavior and eating habits. The influence of sex, weight, and standard length of hosts for parasitic indices was also analyzed. Sixteen helminth species were found parasitizing M. obtusidens, including the following: platyhelminths, with the highest richness, represented by one species of Aspidobothrea; four species of Digenea; and eight species of Monogenea; the latter, presented the highest prevalence. Rhinoxenus arietinus, found in nasal cavities, had the greater abundance, and was the only species classified as core. The prevalence of Urocleidoides paradoxus was significantly influenced by the sex of the host; females had the highest values. Abundance was weakly influenced by fish weight and the body length of the hosts. Urocleidoides sp. had its abundance weakly influenced by the host weight. The other helminths were not influenced by biometric characteristics of the hosts. The total species richness was similar between male and female fish, and both had 14 helminth species of parasites.

Pattern analysis of microtubule-polymerizing and -depolymerizing agent combinations as cancer chemotherapies.

Subcellular distribution of mass can be analyzed by a technique that involves culturing cells on interferometers and digitizing their interference contours. Contour sampling resulted in 102 variables per cell, which were predictors of oncogenic transformation. Cell phenotypes can be deconstructed by use of latent factors, which represent the covariance of the real variables. The reversal of the cancer-type phenotype by a combination of microtubule-stabilizing and -depolymerizing agents was described previously. The implications of these results have been explored by clinicians who treated patients with the combination of docetaxel and vinorelbine (Navelbine). The current study was performed to determine the effects of different combinations on phenotype and in phases of the cell cycle other than mitosis. Combinations of paclitaxel with either colchicine, podophyllotoxin, nocodazole, or vinblastine caused phenotype reversal. Paclitaxel analogue, 7-deoxytaxol, by itself caused reversal. Factors #4, (filopodia), #5 (displacement and/or deep invaginations in the periphery), #8, and #12 took on values typical of normal cells, whereas the values of #7 (p21-activated kinase), and #13 (rounding up) shifted toward the cancer-type. All combinations altered microtubule arrangement at the cell edge. Delivery schedules and drug ratios used in clinical studies were subjected to analysis. Clinical response rates were better when the combination was not interspersed with a single agent (P=0.004). The results support the idea that efficacy depends upon simultaneous exposure to both agents, and suggest a novel mechanism for combination therapies. These therapies appear to restore in transformed cells some of the features of a contact-inhibited cell, and to impede progress through the cell cycle even when provided at nanomolar concentrations.

Throwing behavior and mass distribution of stone selection in tufted capuchin monkeys (Cebus apella).

Cannell [Journal of Archaeological Science 29:335-339, 2002] argued that sex-based differences among humans in terms of the mass of chosen throwing stones could be used to infer body mass and patterns of sexual dimorphism in early hominids from Olduvai and Koobi Fora by examining the mass distributions of unaltered stone tools at those sites. We examined this hypothesis in tufted capuchin monkeys using a comparative approach, by investigating the relationships among body mass, sex, stone weight preference, and accuracy in a throwing task. The subject sample consisted of nine monkeys trained to perform an aimed-throwing task in which a food reward could be obtained by throwing a stone into a bucket. We found that 1) the subjects showed a strong mean stone mass preference; 2) the females chose heavier stones than the males, in terms of absolute mean selected stone mass and selected stone mass relative to body mass; 3) subjects threw more accurately when they used stones of preferred mass vs. stones of nonpreferred mass; and 4) overall, the males were more accurate in the throwing task than the females. We conclude that capuchins are highly selective when choosing throwing stones, and that this confers an advantage for throwing accuracy. Our results indicate that the sexually dimorphic pattern in stone mass preference observed among humans does not generalize to Cebus apella. We suggest that researchers examining this pattern in humans in an attempt to explain early hominid patterns of dimorphism and behavior should take into account not only stone weight preference, but also its adaptive advantage.

Shift of aberrant antigen expression at relapse or at treatment failure in acute leukemia.

The flow cytometric detection of aberrant antigen expression is one method proposed for the quantification of minimal residual disease (MRD) in acute leukemias. The present study was designed to investigate the stability of the aberrant antigen expression at relapse or at treatment failure of initial chemotherapy. For this purpose, multiparameter immunophenotyping with a panel of 15 monoclonal antibodies was used at diagnosis as well as at relapse (43 patients with overall 65 aberrations) and at treatment failure (35 patients with overall 66 aberrations). There was a significant decrease in the percentage of the initially described aberrant antigen expression on leukemia blasts at relapse (P = 0.001; n = 65) as well as at treatment failure (P = 0.0001; n = 66) considering all aberrations in the whole leukemia population. Concerning only patients with acute myelogenous leukemia (AML), significant decreases in the aberrant expression could be detected at relapse (P = 0.031; n = 42) and at treatment failure (P = 0.0001; n = 52). The changes in patients with acute lymphoblastic leukemia (ALL) were significant only at relapse (P = 0.006; n = 23). Initially, the most informative aberration was not detectable in four patients at relapse and in seven patients at treatment failure. A decrease of under 50% of the initial value was observed in another 8 patients at relapse and in 10 patients at treatment failure. In further studies assessing the detection of aberrant antigen expression for MRD, quantification of the relapses should be explicitly analyzed regarding the persistence of the initially described aberrant antigen expression.

Activated microglia are the principal glial source of thromboxane in the central nervous system.

Thromboxane A2(TxA2) is a potent vasoconstrictor associated with cerebrovascular disease and is thought to be synthesized within tissues of the brain. In order to determine the cellular sources of TxA2 in the central nervous system (CNS), we measured the release of the stable metabolite TxB2 in cultures of mixed or highly enriched populations of brain glia. Using techniques which isolated large numbers of highly enriched microglia and astroglia, we found that only microglia release TxB2. Moreover, microglia, not astroglia, contain the requisite synthetic enzyme thromboxane synthase. Phagocytic signals and lipopolysaccharide are potent stimulants of microglial release of thromboxane, with lesser effects shown by platelet activating factor and substance P. We conclude that microglia, when activated, are the principal source of brain-derived thromboxane and may help to control vascular flow at sites of acute CNS injury.

Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain.

Although there is growing evidence that neurotoxic molecules produced by HIV-1-infected mononuclear phagocytes damage neurons, the precise mechanisms of neuronal attack remain uncertain. One class of cytotoxin involves neuronal injury mediated via the NMDA receptor. We examined blood monocytes and brain mononuclear cells isolated at autopsy from HIV-1-infected individuals for the ability to release NMDA-like neuron-killing factors. We found that a neurotoxic amine, NTox, was produced by blood monocytes and by brain mononuclear phagocytes infected with retrovirus. In vivo injections of minute quantities of NTox produced selective damage to hippocampal pyramidal neurons. NTox can be extracted directly from brain tissues infected with HIV-1 and showed structural features similar to wasp and spider venoms. In contrast to NTox, HIV-1 infection did not increase the release of the NMDA excitotoxin quinolinic acid (QUIN) from mononuclear cells. Although we found modest elevations of QUIN in the CSF of HIV-1-infected individuals, the increases were likely attributable to entry through damaged blood-brain barrier. Taken together, our data pinpoint NTox, rather than QUIN, as a major NMDA receptor-directed toxin associated with neuro-AIDS.

The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes.

Mononuclear phagocytes infected with human immunodeficiency virus 1 (HIV-1) produce soluble factors that kill neurons in culture. To define the molecular events that lead to neuron killing, HIV-1 proteins were tested for the ability to trigger release of neurotoxins from human monocytes and lymphocytes. None of the recombinant-derived HIV-1 proteins examined (reverse transcriptase, protease, gag, nef, or gp120) were directly neurotoxic at concentrations from 100 pM to 10 nM. The envelope glycoprotein gp120 did, however, stimulate both isolated human blood monocytes and the monocytoid line THP-1 (but not lymphocytes or the lymphoid cell line H9) to discharge neurotoxic factors. These toxins consisted of heat-stable, protease-resistant molecules (< 500 Da) that copurified with neurotoxins from HIV-1-infected THP-1 cells and were blocked by antagonists to N-methyl-D-aspartate receptors. Release of neurotoxins through gp120 stimulation involved monocytoid CD4 receptors because toxin production could be inhibited either by a monoclonal antibody to the CD4-binding region of gp120 or by soluble CD4 receptors. Alternatively, production of neuron-killing factors could be induced with a peptide from the CD4-binding region of gp120. These data show that the HIV-1 envelope glycoprotein alone can stimulate neurotoxin release by binding to CD4 receptors of mononuclear phagocytes. Such neurotoxic factors may, in turn, contribute to the central nervous system dysfunction associated with HIV-1 by acting on neurons through N-methyl-D-aspartate receptors.

Divergent effects of astroglial and microglial secretions on neuron growth and survival.

Brain glia have a secretory capacity which can modulate neuronal function. Astrocytes release proteins which enhance neuronal survival and induce neuronal growth and differentiation. These effects can be blocked by antagonists of voltage-dependent calcium channels and may be partly mimicked by Bay K 8644, a calcium channel agonist. Two of these neurotrophic proteins appear, on the basis of their physical properties and effects on ciliary ganglion neurons, to be ciliary neurotrophic factor and basic fibroblast growth factor. Activated microglia release a heat- and protease-stable neurotoxin of low molecular weight. This neurotoxicity is blocked by NMDA receptor antagonists. Ciliary neurons exposed to the microglial neurotoxin exhibit an abnormal distribution of neurofilament immunoreactivity, which becomes concentrated in a perinuclear region, while the astroglial growth factors induce neurofilament organization into an extensive neuritic network. The astrocyte-released growth factors can counteract the effect of the microglial neurotoxin and lead to unimpaired neural differentiation in the presence of the neurotoxin.

Certification of occupational therapists in the public schools: the Wisconsin experience.

The history of public school certification for occupational and physical therapists is reviewed. The process used to develop the current standards for certification of public school occupational therapists in Wisconsin and the standards that resulted are described. The implications of school certification requirements are discussed in terms of basic professional education in occupational therapy, and recommendations are made regarding the establishment of certification standards for school-based therapists.

[Glutamate-oxalacetate-transaminase in irradiated and nonirradiated chick embryos]. / Untersuchunger der Glutamat-Oxalazetat-Transaminase bei bestrahlten und unbestrahlten Hühnerembryonen

The enzymatic activity of glutamate-oxalacetate transaminase (GOT) in 16 days old chick embryos was investigated in 10 minute-intervals following X-ray irradiation with 1000 R. Initially, in the tissue homogenates of the embryos and in the blood serum a decline of enzyme activity was observed, which continued for 30 minutes after irradiation. Subsequently - during a second phase - the enzymatic action was increased far beyond the norm. On the contrary, in the tissues of the allantois no significant change of the GOT-concentration was seen following irradiation.